Stay updated on Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedThe history now shows a new Revision: v3.3.4 and the removal of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added, and the entries 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page, with no visible changes to study history content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedDeleted the general operating-status notice from the page. Core trial history and linkable versions remain unchanged.SummaryDifference0.6%

- Check73 days agoChange DetectedThe screenshots indicate a cosmetic redesign of the Record History page with a different layout and styling, while the underlying content and version entries remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check102 days agoChange DetectedUpdated operating status and version: old status/revision removed and new funding notice, current NIH Clinical Center status, and revision v3.2.0 added.SummaryDifference14%

Stay in the know with updates to Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.